NHIA Member Home
Find a Provider

News Category: Infusion News

Congress Takes Steps Toward Expanding Home Infusion Access

  • February 3, 2026
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to certain health care provider-administered drugs if an infusion pump is required for administration. Passage of H.R. 4993, the Joe Fiandra Access to Home Infusion Act, reflects Congress’ recognition of the strong patient interest—including among individuals with rare diseases—in home infusion access.

NHIA Testifies at Congressional Hearing as Momentum Builds to Fix Medicare’s Home Infusion Benefit

  • January 8, 2026
National Home Infusion Association (NHIA) President and CEO Connie Sullivan testified today before the House Energy and Commerce Committee Subcommittee on Health in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172). The hearing marked a major milestone for the legislation, with Members from both parties emphasizing the need to strengthen Medicare and remove barriers that keep seniors from receiving clinically appropriate infusion care at home.

NHIA Welcomes Inovalon to the Future of Infusion Advisory Council

  • January 5, 2026
The National Home Infusion Association (NHIA) and Inovalon are pleased to announce the addition of Inovalon to NHIA’s Future of Infusion Advisory Council (FIAC).

Stability of Immune Globulin Intravenous, Human-stwk, 10% Liquid Following Pooling and Storage in Flexible Containers

July 29, 2025

Full text | Download pdf

https://doi.org/10.70776/PNTG6835

Stacey Ness PharmD, IgCP, CSP, MSCS, AAHIVP GC Biopharma USA | Alan Huber BSc Pharm, PharmD, MBA GC Biopharma USA | Suzanne Strasters MSN, FNP-C, IgCN GC Biopharma USA | Nari Ji GC Biopharma Yongin-si, South Korea | JaeWoon Son, PhD. GC Biopharma Yongin-si, South Korea

Immune globulin intravenous, human-stwk, 10% liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. Unopened immune globulin intravenous, human-stwk, 10% liquid in its original container may be stored under refrigerated conditions at (2-8°C/36-46°F) for 36 months or may be stored for 24 months at room temperature (25°C/77°F) from the date it was manufactured. However, pooling intravenous immune globulin from several vials into a single container (usually a flexible bag) under aseptic conditions prior to administration is sometimes desirable in clinical practice.

Read More »

HHS Secretary Kennedy Supports Home Infusion at House E&C Hearing

June 24, 2025

NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.

Read More »

NHIA Comments on MTF for 2026 and 2027

May 1, 2025

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

April 18, 2025

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

April 8, 2025

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »

Use of a Lipid Screening Tool to Identify Patients at Greater Risk of Infusion Reactions to Lipids in the Home Setting

March 25, 2025

Full text | Download pdf

https://doi.org/10.70776/TMPJ4448

Yoselin Flores, PharmD Option Care Health | Jessica Monczka, RD, CNSC, FASPEN Option Care Health | Maria Giannakos, PharmD, MBA, BCPS, BCSCP, FNHIA Option Care Health | Annemarie Hocking, PharmD Option Care Health | Suzanne Kluge, BSPharm, MBA, BCSCP, FNHIA Option Care Health

The primary objective of this study was to compare the resources utilized when using a lipid risk screening tool versus the resources utilized previously without the use of a lipid risk screening tool. Specifically, this study assessed nursing time and drug costs related to the dispensing of anaphylaxis kits. The secondary objective was to assess the tolerability of ILE first doses in the home. It was hypothesized that ILE first doses in the home would be well tolerated after clinical review of patients using the lipid risk screening tool.

Read More »

NHIF Outstanding Abstract Achievement Award Finalists

March 25, 2025

Full text | Download pdf

Recognizing Excellence in Home and Specialty Infusion Research: The NHIF Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) is proud to announce the finalists for the 2025 Outstanding Abstract Achievement Award, a recognition of groundbreaking research that advances best practices in home and specialty infusion. Each year, this award highlights innovative approaches, quality improvements, and solutions to critical challenges within the field.

Read More »

Preference for Inebilizumab Home Infusion Among People with Neuromyelitis Optica Spectrum Disorder

March 25, 2025

Full text | Download pdf

https://doi.org/10.70776/TAMR6122

Gerome Vallejos, MD, Harvard Medical School, Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology | Gabriela Romanow, Harvard Medical School, Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology | Michael Levy, MD, PhD, Harvard Medical School Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology

To determine whether people with neuromyelitis optica spectrum disorder (NMOSD) prefer to receive inebilizumab infusions at home versus in an infusion center or hospital, and to assess how that choice affects their quality of life.

Read More »

Pentec Health and Vital Care Infusion Services to Join NHIA Board of Directors

March 25, 2025

NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.

Read More »

NHIA Announces 2025 Class of Fellows

February 24, 2025

The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »

Stability of Immune Globulin Intravenous, Human-stwk, 10% Liquid Following Pooling and Storage in Flexible Containers

July 29, 2025

Full text | Download pdf

https://doi.org/10.70776/PNTG6835

Stacey Ness PharmD, IgCP, CSP, MSCS, AAHIVP GC Biopharma USA | Alan Huber BSc Pharm, PharmD, MBA GC Biopharma USA | Suzanne Strasters MSN, FNP-C, IgCN GC Biopharma USA | Nari Ji GC Biopharma Yongin-si, South Korea | JaeWoon Son, PhD. GC Biopharma Yongin-si, South Korea

Immune globulin intravenous, human-stwk, 10% liquid is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. Unopened immune globulin intravenous, human-stwk, 10% liquid in its original container may be stored under refrigerated conditions at (2-8°C/36-46°F) for 36 months or may be stored for 24 months at room temperature (25°C/77°F) from the date it was manufactured. However, pooling intravenous immune globulin from several vials into a single container (usually a flexible bag) under aseptic conditions prior to administration is sometimes desirable in clinical practice.

Read More »

HHS Secretary Kennedy Supports Home Infusion at House E&C Hearing

June 24, 2025

NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.

Read More »

NHIA Comments on MTF for 2026 and 2027

May 1, 2025

NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.

Read More »

NHIA Announces Greg LoPresti to Lead Board of Directors

April 18, 2025

The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.

Read More »

NHIA 2025 Features Largest Home Infusion Expo & Builds a Roadmap for Progress

April 8, 2025

Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.

Read More »

Use of a Lipid Screening Tool to Identify Patients at Greater Risk of Infusion Reactions to Lipids in the Home Setting

March 25, 2025

Full text | Download pdf

https://doi.org/10.70776/TMPJ4448

Yoselin Flores, PharmD Option Care Health | Jessica Monczka, RD, CNSC, FASPEN Option Care Health | Maria Giannakos, PharmD, MBA, BCPS, BCSCP, FNHIA Option Care Health | Annemarie Hocking, PharmD Option Care Health | Suzanne Kluge, BSPharm, MBA, BCSCP, FNHIA Option Care Health

The primary objective of this study was to compare the resources utilized when using a lipid risk screening tool versus the resources utilized previously without the use of a lipid risk screening tool. Specifically, this study assessed nursing time and drug costs related to the dispensing of anaphylaxis kits. The secondary objective was to assess the tolerability of ILE first doses in the home. It was hypothesized that ILE first doses in the home would be well tolerated after clinical review of patients using the lipid risk screening tool.

Read More »

NHIF Outstanding Abstract Achievement Award Finalists

March 25, 2025

Full text | Download pdf

Recognizing Excellence in Home and Specialty Infusion Research: The NHIF Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) is proud to announce the finalists for the 2025 Outstanding Abstract Achievement Award, a recognition of groundbreaking research that advances best practices in home and specialty infusion. Each year, this award highlights innovative approaches, quality improvements, and solutions to critical challenges within the field.

Read More »

Preference for Inebilizumab Home Infusion Among People with Neuromyelitis Optica Spectrum Disorder

March 25, 2025

Full text | Download pdf

https://doi.org/10.70776/TAMR6122

Gerome Vallejos, MD, Harvard Medical School, Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology | Gabriela Romanow, Harvard Medical School, Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology | Michael Levy, MD, PhD, Harvard Medical School Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology

To determine whether people with neuromyelitis optica spectrum disorder (NMOSD) prefer to receive inebilizumab infusions at home versus in an infusion center or hospital, and to assess how that choice affects their quality of life.

Read More »

Pentec Health and Vital Care Infusion Services to Join NHIA Board of Directors

March 25, 2025

NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.

Read More »

NHIA Announces 2025 Class of Fellows

February 24, 2025

The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »
News Archive